BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
See today's BioWorld
Home
» Neurotransmitter GABA could be target for antidepressants
To read the full story,
subscribe
or
sign in
.
Neurotransmitter GABA could be target for antidepressants
Nov. 11, 2016
By
Anette Breindl
Currently, standard antidepressants – the selective serotonin reuptake inhibitors (SSRIs) – target serotonin. But serotonin is far from the only transmitter that is out of balance in depression.
BioWorld